Biopsies were carried out, resulting in a diagnosis of poorly differentiated lung adenocarcinoma with a high expression of PDL-1 (60%) and L858R mutation in exon 21 of the EGFR gene (Oncomine Pan-Cancer Cell-Free Assay). This evidence concerns the gene EGFR and cancer.